EFFECT OF A LIGHT STIMULATED FOOTSTEPS PATHWAY ON GAIT IN SPASTIC CHILDREN
NCT ID: NCT07289347
Last Updated: 2025-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
30 participants
INTERVENTIONAL
2025-09-20
2025-12-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
HYPOTHESES: Walking on light stimulated footsteps pathway may not affect kinematics of gait in spastic diplegic children RESEARCH QUESTION: Does walking on light stimulated footsteps pathway have any effect onkinematics of gait in spastic diplegic children?
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
This group of fifteen children received a regular traditional therapeutic exercise program based on the Pragmatic approach.
therapeutic exercise
Balance training from different positions. Weight shifting exercises by facilitation of single limb support while standing.
Ascending and descending stairs. Gait training between parallel bars
Group B
The fifteen children in this group got the same therapeutic exercise program as the control group, as well as 30 minutes of gait training on light stimulated footsteps pathway.
therapeutic exercise
Balance training from different positions. Weight shifting exercises by facilitation of single limb support while standing.
Ascending and descending stairs. Gait training between parallel bars
gait training on light stimulated footsteps pathway
same routine program as the control group as well as 30 minutes of gait training on light stimulated footsteps pathway:
1. Walk on the light stimulated footsteps (Forward steps)
2. Walk on the light stimulated footsteps (backward steps)
3. Tandem gait over light yellow line
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
therapeutic exercise
Balance training from different positions. Weight shifting exercises by facilitation of single limb support while standing.
Ascending and descending stairs. Gait training between parallel bars
gait training on light stimulated footsteps pathway
same routine program as the control group as well as 30 minutes of gait training on light stimulated footsteps pathway:
1. Walk on the light stimulated footsteps (Forward steps)
2. Walk on the light stimulated footsteps (backward steps)
3. Tandem gait over light yellow line
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* They had Grade 1 and 1+ hypertonia according to Modified Ashworth Scale (Bohannon and Smith, 1987)
* Motor Classification System, they were at level I and II (GMFCS)
* They will capable of following commands and comprehend them.
* They will exhibit defective gait kinematics, which can be determined through gait kinematics evaluation.
* All patients who will be enrolled to the study will have their informed consent.
Exclusion Criteria
* Taking any anti spastic drugs.
* Both lower limbs had permanent deformity.
* Surgical intervention history.
* Have visual or auditory defects.
* Chest infections or unstable cardiac status.
* Infective skin conditions.
* Markedly high or low blood pressure.
* Individuals with cardiopulmonary conditions.
* Individuals with any pelvic disease.
* Individuals undergoing radiation therapy or chemotherapy.
* Hepatic or pancreatic diseases.
4 Years
8 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amira saad mohamed
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amira saad mohamed
lecturer of physical therapy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
012/006097
Identifier Type: -
Identifier Source: org_study_id